ROYAL OAK -- Over the past two decades, cardiologists have explored many different treatments to help prevent permanent heart damage after a heart attack. One treatment that appears to be very ...
SAN DIEGO - A physician at Scripps Health's Prebys Cardiovascular Institute has become the first in the Western United States to treat heart attack patients with a new supersaturated oxygen (SSO2) ...
Henry Mayo Newhall Hospital is one of the first hospitals in Southern California to improve treatment of "widowmaker" heart ...
Results of a clinical trial demonstrate that an infusion of blood that is "supersaturated" with oxygen (SS02) can reduce the amount of damaged heart muscle immediately following a life-threatening ...
IRVINE, Calif.--(BUSINESS WIRE)--TherOx, a ZOLL ® Medical company, announces key data presentations and company-sponsored events for SuperSaturated Oxygen (SSO 2) Therapy at the upcoming Transcatheter ...
CHELMSFORD, Mass., October 31, 2022--(BUSINESS WIRE)--ZOLL, an Asahi Kasei company that manufactures medical devices and related software solutions, announced today that its TherOx SuperSaturated ...
The Prebys Cardiovascular Institute in La Jolla is taking part in a nationwide clinical trial of a technique that uses supersaturated oxygen to reduce tissue damage suffered by heart attack patients, ...
TherOx, an Irvine, Calif.-based medical device company, seeks $25 million for the final push to bring its treatment to increase the quality of life for heart attack patients. The company’s optimized ...
IRVINE, Calif.--(BUSINESS WIRE)--TherOx, Inc., a privately held medical device company focused on improved treatment of Acute Myocardial Infarction (AMI), announced it has received U.S. Food and Drug ...
A physician at Scripps Health's Prebys Cardiovascular Institute has become the first in the Western United States to treat heart attack patients with a new supersaturated oxygen (SSO2) system in an ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results